Q1 2019 EPS Estimates for Davita Inc (DVA) Lowered by William Blair

Davita Inc (NYSE:DVA) – Research analysts at William Blair reduced their Q1 2019 earnings per share estimates for Davita in a report released on Wednesday, February 13th. William Blair analyst M. Larew now anticipates that the company will post earnings of $1.05 per share for the quarter, down from their prior forecast of $1.07. William Blair also issued estimates for Davita’s Q2 2019 earnings at $1.05 EPS.

Get Davita alerts:

A number of other brokerages have also recently commented on DVA. Zacks Investment Research cut shares of Davita from a “hold” rating to a “sell” rating in a report on Tuesday, November 13th. Royal Bank of Canada restated a “hold” rating and set a $65.00 target price on shares of Davita in a report on Wednesday, January 9th. Deutsche Bank started coverage on shares of Davita in a report on Thursday, January 3rd. They set a “buy” rating and a $60.00 target price on the stock. Barclays started coverage on shares of Davita in a report on Friday, December 14th. They set an “overweight” rating and a $70.00 target price on the stock. Finally, ValuEngine cut shares of Davita from a “hold” rating to a “sell” rating in a report on Wednesday, January 2nd. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have given a buy rating to the stock. Davita presently has a consensus rating of “Hold” and a consensus target price of $66.41.

Shares of DVA stock opened at $58.09 on Friday. Davita has a 12 month low of $48.25 and a 12 month high of $79.11. The firm has a market cap of $9.61 billion, a PE ratio of 16.27, a price-to-earnings-growth ratio of 0.59 and a beta of 1.31. The company has a current ratio of 1.84, a quick ratio of 1.82 and a debt-to-equity ratio of 2.09.

Davita (NYSE:DVA) last announced its earnings results on Wednesday, February 13th. The company reported $0.90 EPS for the quarter, beating the Zacks’ consensus estimate of $0.89 by $0.01. Davita had a net margin of 1.40% and a return on equity of 13.75%. The firm had revenue of $2.82 billion for the quarter, compared to analysts’ expectations of $2.97 billion. During the same quarter in the previous year, the business posted $0.92 EPS. The company’s quarterly revenue was up 1.4% on a year-over-year basis.

Several institutional investors and hedge funds have recently bought and sold shares of the company. Quantamental Technologies LLC purchased a new position in Davita in the 4th quarter worth about $34,000. Fort L.P. purchased a new position in Davita in the 4th quarter worth about $76,000. Honkamp Krueger Financial Services Inc. purchased a new position in Davita in the 3rd quarter worth about $143,000. Dupont Capital Management Corp raised its position in Davita by 41.0% in the 4th quarter. Dupont Capital Management Corp now owns 2,525 shares of the company’s stock worth $130,000 after buying an additional 734 shares during the last quarter. Finally, Atlas Capital Advisors LLC raised its position in Davita by 247.9% in the 3rd quarter. Atlas Capital Advisors LLC now owns 2,592 shares of the company’s stock worth $188,000 after buying an additional 1,847 shares during the last quarter. 85.99% of the stock is owned by hedge funds and other institutional investors.

Davita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Recommended Story: What are the benefits of buying treasury bonds?